Changing Hospital Economics Force Medical Device Industry To Adapt
This article was originally published in The Gray Sheet
Executive SummaryGrowing pressures on hospitals will challenge medical device firms to update their sales and marketing strategies, according to speakers at the AdvaMed 2011 Medtech Conference held Sept. 26-28 in Washington, D.C.
You may also be interested in...
Reforms to the US 180-day exclusivity incentive included in the Blocking Act that is part of the Lower Health Care Costs Act could cost the US healthcare system approximately $1.7bn, the AAM has warned.
Moderate growth at Bristol-Myers Squibb and Amgen moved the two companies into the top 10 pharma ranks, based on the most recent Scrip 100 rankings, while declining growth at Gilead and Teva moved those drug makers out.